News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,251 Results
Type
Article (87901)
Company Profile (825)
Press Release (780510)
Multimedia
Podcasts (191)
Webinars (28)
Section
Business (233240)
Career Advice (4145)
Deals (39867)
Drug Delivery (145)
Drug Development (91398)
Employer Resources (203)
FDA (18378)
Job Trends (17421)
News (397851)
Policy (39961)
Tag
Academia (3006)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (335)
Approvals (18547)
Artificial intelligence (614)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (160)
Brain cancer (64)
Breast cancer (645)
Cancer (4926)
Cardiovascular disease (433)
Career advice (3567)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (815)
Cervical cancer (37)
Clinical research (76895)
Collaboration (1750)
Company closure (5)
Compensation (1122)
Complete response letters (70)
COVID-19 (2988)
CRISPR (96)
C-suite (827)
Cystic fibrosis (154)
Data (6150)
Decentralized trials (2)
Denatured (70)
Depression (146)
Diabetes (526)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (294)
Drug pricing (220)
Drug shortages (36)
Duchenne muscular dystrophy (233)
Earnings (100037)
Editorial (61)
Employer branding (25)
Employer resources (173)
Events (134967)
Executive appointments (1025)
FDA (21451)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1532)
Gene editing (210)
Generative AI (62)
Gene therapy (661)
GLP-1 (1110)
Government (5432)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (54)
Indications (84)
Infectious disease (3272)
Inflammatory bowel disease (202)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (239)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (657)
Leadership (39)
Legal (10158)
Liver cancer (97)
Longevity (14)
Lung cancer (673)
Lymphoma (369)
Machine learning (43)
Management (66)
Manufacturing (820)
MASH (171)
Medical device (15001)
Medtech (15045)
Mergers & acquisitions (22954)
Metabolic disorders (1367)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (342)
Neuropsychiatric disorders (93)
Neuroscience (3067)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (63)
Obesity (657)
Opinion (331)
Ovarian cancer (162)
Pain (198)
Pancreatic cancer (226)
Parkinson's disease (288)
Partnered (38)
Patents (490)
Patient recruitment (458)
Peanut (60)
People (66818)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23765)
Phase II (33362)
Phase III (25151)
Pipeline (4685)
Policy (329)
Postmarket research (3554)
Preclinical (10682)
Press Release (72)
Prostate cancer (239)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (868)
Real estate (7437)
Recruiting (80)
Regulatory (28864)
Reports (65)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (98)
The Weekly (119)
Vaccines (1129)
Venture capital (92)
Weight loss (455)
Women's health (85)
Worklife (21)
Date
Today (79)
Last 7 days (611)
Last 30 days (2127)
Last 365 days (33169)
2026 (1564)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51494)
Australia (9034)
California (11329)
Canada (3264)
China (1134)
Colorado (477)
Connecticut (492)
Delaware (342)
Europe (118299)
Florida (1655)
Georgia (363)
Hawaii (3)
Idaho (68)
Illinois (942)
India (66)
Indiana (534)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1440)
Massachusetts (8382)
Michigan (349)
Minnesota (649)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (123)
New Hampshire (85)
New Jersey (3063)
New Mexico (33)
New York (3005)
North Carolina (1585)
North Dakota (10)
Northern California (5400)
Ohio (348)
Oklahoma (22)
Oregon (54)
Pennsylvania (2271)
Puerto Rico (21)
Rhode Island (49)
South America (1657)
South Carolina (62)
South Dakota (1)
Southern California (4364)
Tennessee (173)
Texas (1787)
United States (40989)
Utah (340)
Vermont (1)
Virginia (283)
Washington D.C. (85)
Washington State (953)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,251 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of
C. Diff
Drug
Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of
the Cambridge, Massachusetts–based biotech’s workforce is being cut while most of the rest are furloughed.
January 16, 2026
·
2 min read
·
Angela Gabriel
Business
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Following rusfertide’s triumphant Phase III trial last year, Protagonist must decide how involved to be in future development. Hundreds of millions of dollars are on the line.
January 16, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
January 16, 2026
·
8 min read
Press Releases
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
January 16, 2026
·
8 min read
Press Releases
Liposomes Market Size Hits USD 10.08 Billion by 2032 Amid Rising Demand for Advanced Drug Delivery Systems | Coherent Market Insights
January 16, 2026
·
1 min read
Press Releases
Brugada Syndrome Market Size to Exceed USD 2.08 Billion by 2032 on Rising Awareness and Early Diagnosis | Coherent Market Insights
January 16, 2026
·
1 min read
Press Releases
Fibroblast Growth Factors Market Size to worth US$ 6.43 Billion by 2032, Coherent Market Insights
January 16, 2026
·
1 min read
Press Releases
Nasal Irrigation Market Size to Worth US$ 1,695.5 Million by 2032 by Rising Prevalence of Nasal and Respiratory Conditions | Coherent Market Insights
January 16, 2026
·
1 min read
Press Releases
ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma
January 16, 2026
·
11 min read
Press Releases
ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG
January 16, 2026
·
9 min read
1 of 86,926
Next
